Page last updated: 2024-10-21

2-fluorohexadecanoic acid and Brain Neoplasms

2-fluorohexadecanoic acid has been researched along with Brain Neoplasms in 1 studies

2-fluorohexadecanoic acid: inhibits sphingosine base formation & accumulates in membrane lipids of cultured mammalian cells

Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Jiapaer, S1
Furuta, T1
Dong, Y1
Kitabayashi, T1
Sabit, H1
Zhang, J1
Zhang, G1
Tanaka, S1
Kobayashi, M1
Hirao, A1
Nakada, M1

Other Studies

1 other study available for 2-fluorohexadecanoic acid and Brain Neoplasms

ArticleYear
Identification of 2-Fluoropalmitic Acid as a Potential Therapeutic Agent Against Glioblastoma.
    Current pharmaceutical design, 2020, Volume: 26, Issue:36

    Topics: Brain Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Glioblastoma; Humans; Palmitic Acids;

2020